Effect of Rituximab on Neurofilament Levels in <scp>CIDP</scp> : Results From the <scp>CIDPRIT</scp> Randomized Trial
The analysis did not demonstrate biomarker-based evidence of rituximab efficacy in CIDP. However, observed trends suggest a possible biological effect in reducing axonal injury in a subset of patients. Further studies are needed to clarify the role of sNfL in treatment monitoring and patient stratification.
Authors
- L. Querol
- Chiara Gallo (ORCID: https://orcid.org/0000-0002-8606-3533)
- Elisa Bianchi (ORCID: https://orcid.org/0000-0002-6110-5944)
- Luca Gentile (ORCID: https://orcid.org/0000-0002-7393-7502)
- Yuri Falzone (ORCID: https://orcid.org/0000-0003-3233-1907)
- Luana Benedetti
- Erdita Peci
- Camilla Strano
- Giuseppe Liberatore
- Claudia Cutellè
- Fiore Manganelli
- Francesco Germano
- Anna Mazzeo
- Roger Collet-Vidiella
- Eduardo Nobile-Orazio
- Dario Cocito
- Eleonora Dalla Bella
Institutions
- University of Messina (IT)
- Humanitas University (IT)
- Vita-Salute San Raffaele University (IT)
- University of Milan (IT)
- Mario Negri Institute for Pharmacological Research (IT)
- Hospital de Sant Pau (ES)
- San Raffaele University of Rome (IT)
- Federico II University Hospital (IT)
- Molecular Cardiology and Neuromuscular Institute (US)
- Ospedale Policlinico San Martino (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- IRCCS Humanitas Research Hospital (IT)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- University of Turin (IT)
- University of Naples Federico II (IT)
- University of Genoa (IT)
Publication Details
- Journal
- Journal of the Peripheral Nervous System
- Published
- 2026-02-06
- DOI
- https://doi.org/10.1111/jns.70107
- Primary Topic
- Skin and Cellular Biology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00